LYPD3 anticorps
Aperçu rapide pour LYPD3 anticorps (ABIN7091336)
Antigène
Voir toutes LYPD3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Réactivité croisée
- Humain
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human LYPD3
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB 1:300-5000
IHC-P 1:200-400
IF()
ICC 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Date de péremption
- 12 months
-
-
- LYPD3 (LY6/PLAUR Domain Containing 3 (LYPD3))
-
Autre désignation
- LYPD3
-
Sujet
-
Synonyms: C4.4A, FLJ10525, GPI-anchored metastasis-associated protein C4.4A homolog, GPI-anchored metastasis-associated protein homolog, Ly6/PLAUR domain-containing protein 3, LYPD3_HUMAN, Matrigel-induced gene C4 protein, MIG-C4, SHINC3.
Background: Predicted to enable laminin binding activity. Predicted to act upstream of or within cell-matrix adhesion. Located in extracellular space. [provided by Alliance of Genome Resources, Nov 2021]
-
ID gène
- 27076
-
UniProt
- O95274
Antigène
-